| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Renal Failure | |||||
| Left Ventricular Hypertrophy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Arteriovenous Fistula | |||||
| Hypertrophy | |||||
| Hypertrophy, Left Ventricular | |||||
| Kidney Failure | |||||
| 3 | More general conditions related to this trial | ||||
| Arteriovenous Malformations | |||||
| Cardiomegaly | |||||
| Cardiovascular Abnormalities | |||||
| Cardiovascular Diseases | |||||
| Congenital Abnormalities | |||||
| Fistula | |||||
| Heart Diseases | |||||
| Kidney Diseases | |||||
| Pathological Conditions, Anatomical | |||||
| Renal Insufficiency | |||||
| Urologic Diseases | |||||
| Vascular Diseases | |||||
| Vascular Fistula | |||||
| Vascular Malformations | |||||
| 4 | Interventions listed in this trial | ||||
| losartan | |||||
| 5 | More general drug interventions related to this trial | ||||
| Angiotensin II Type 1 Receptor Blockers | |||||
| Anti-Arrhythmia Agents | |||||
| Antihypertensive Agents | |||||
| Cardiovascular Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Melbourne Health | |||||
|
